AMLX vs. GBIL

Last updated Jun 4, 2026

AMLX (Amylyx Pharmaceuticals, Inc.) is a stock, while GBIL (Goldman Sachs Access Treasury 0-1 Year ETF) is Government Bonds fund tracking the FTSE US Treasury 0-1 Year Composite Select Index. Over the past 3 years, AMLX returned -19.37%/yr vs 4.64%/yr for GBIL. At a correlation of -0.02, they often move in opposite directions.

Performance

AMLX vs. GBIL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amylyx Pharmaceuticals, Inc. (AMLX) and Goldman Sachs Access Treasury 0-1 Year ETF (GBIL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AMLX achieves a 9.27% return, which is significantly higher than GBIL's 1.42% return.

AMLX

• 1D: -0.68%
• 1M: -19.81%
• YTD: 9.27%
• 6M: -7.11%
• 1Y: 157.81%
• 3Y*: -19.37%
• 5Y*: —
• 10Y*: —

GBIL

• 1D: 0.02%
• 1M: 0.28%
• YTD: 1.42%
• 6M: 1.73%
• 1Y: 3.91%
• 3Y*: 4.64%
• 5Y*: 3.32%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AMLX vs. GBIL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
AMLX Amylyx Pharmaceuticals, Inc.	9.27%	219.58%	-74.32%	-60.16%	104.48%
GBIL Goldman Sachs Access Treasury 0-1 Year ETF	1.42%	4.12%	5.24%	4.91%	1.05%

Correlation

The correlation between AMLX and GBIL is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	-0.01
Correlation (All Time) Calculated using the full available price history since Jan 10, 2022	-0.02

Return for Risk

AMLX vs. GBIL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMLX

AMLX Risk / Return Rank: 89
AMLX Sharpe Ratio Rank: 91
AMLX Sortino Ratio Rank: 90
AMLX Omega Ratio Rank: 85
AMLX Calmar Ratio Rank: 91
AMLX Martin Ratio Rank: 89

GBIL

GBIL Risk / Return Rank: 100
GBIL Sharpe Ratio Rank: 100
GBIL Sortino Ratio Rank: 100
GBIL Omega Ratio Rank: 100
GBIL Calmar Ratio Rank: 100
GBIL Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMLX vs. GBIL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amylyx Pharmaceuticals, Inc. (AMLX) and Goldman Sachs Access Treasury 0-1 Year ETF (GBIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AMLX	GBIL	Difference
Sharpe ratio: Return per unit of total volatility	2.37	16.89	-14.51
Sortino ratio: Return per unit of downside risk	3.20	102.89	-99.69
Omega ratio: Gain probability vs. loss probability	1.36	39.42	-38.06
Calmar ratio: Return relative to maximum drawdown	5.19	196.43	-191.25
Martin ratio: Return relative to average drawdown	11.73	1,608.66	-1,596.94
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AMLX vs. GBIL - Sharpe Ratio Comparison

The current AMLX Sharpe Ratio is 2.37, which is lower than the GBIL Sharpe Ratio of 16.89. The chart below compares the historical Sharpe Ratios of AMLX and GBIL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	AMLX	GBIL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.37	16.89	-14.51
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	5.78	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.08	4.87	-4.95

Drawdowns

AMLX vs. GBIL - Drawdown Comparison

The maximum AMLX drawdown since its inception was -96.04%, which is greater than GBIL's maximum drawdown of -0.76%. Use the drawdown chart below to compare losses from any high point for AMLX and GBIL.

Drawdown Indicators

	AMLX	GBIL	Difference
Max Drawdown Largest peak-to-trough decline	-96.04%	-0.76%	-95.28%
Max Drawdown (1Y) Largest decline over 1 year	-30.61%	-0.02%	-30.59%
Max Drawdown (3Y) Largest decline over 3 years	-93.83%	-0.76%	-93.07%
Max Drawdown (5Y) Largest decline over 5 years	—	-0.76%	—
Current Drawdown Current decline from peak	-67.75%	0.00%	-67.75%
Average Drawdown Average peak-to-trough decline	-59.36%	-0.04%	-59.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.52%	0.00%	+13.52%

Volatility

AMLX vs. GBIL - Volatility Comparison

Amylyx Pharmaceuticals, Inc. (AMLX) has a higher volatility of 14.15% compared to Goldman Sachs Access Treasury 0-1 Year ETF (GBIL) at 0.04%. This indicates that AMLX's price experiences larger fluctuations and is considered to be riskier than GBIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AMLX	GBIL	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.15%	0.04%	+14.11%
Volatility (6M) Calculated over the trailing 6-month period	41.86%	0.14%	+41.72%
Volatility (1Y) Calculated over the trailing 1-year period	66.96%	0.23%	+66.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	91.49%	0.58%	+90.91%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	91.49%	0.47%	+91.02%

Dividends

AMLX vs. GBIL - Dividend Comparison

AMLX has not paid dividends to shareholders, while GBIL's dividend yield for the trailing twelve months is around 3.74%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
AMLX Amylyx Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
GBIL Goldman Sachs Access Treasury 0-1 Year ETF	3.74%	4.02%	4.93%	4.77%	1.37%	0.00%	0.81%	2.20%	1.70%	0.74%	0.11%

Frequently Asked Questions

Can I hold both AMLX and GBIL in my portfolio?

AMLX and GBIL have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AMLX or GBIL?

AMLX has higher volatility (14.15%) compared to GBIL (0.04%). In terms of maximum drawdown, AMLX dropped -96.04% vs GBIL's -0.76%.

Which has better risk-adjusted returns?

GBIL currently has the higher Sharpe Ratio (16.89 vs 2.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.